Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-08-09

Clinical Trial Update: Low Dose Doxycycline in the Treatment of Corneal Burn [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial is evaluating low-dose doxycycline for the treatment of corneal burns. Phase 2 and Phase 3 are listed, with status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxycycline (Doxycycline)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Eye Burns | Phase 2, Phase 3 | Status: UNKNOWN